Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Patient characteristics by medical conditions pre-and post-prescription law. by Megan Armstrong (1782073)

Subjects:

Fig 2 - by Megan Armstrong (1782073)

Subjects:

CONSORT diagram for prospective survey recruitment. by Megan Armstrong (1782073)

Subjects:

Opioid medication use and patient satisfaction after hospital discharge. by Megan Armstrong (1782073)

Subjects:

Plot of mean vigor by group and time. by Kunal Desai (18784208)

Subjects:

Plot of mean Burnout by group and time. by Kunal Desai (18784208)

Subjects:

Changes in physiological parameters of Long-Evans rats after oral administration of <i>G</i>. <i>tsugae</i>. by Hui-Chuan Kuo (12368492)

Subjects:

Changes in expression of ATF-3 and NeuN in the DRGs of PSNL-exposed rats and the effects of treatment with MSCs. by Kanako Miyano (3805288)

Subjects:

Pain intensity amplification with either increases or decreases are independent of temperature but are correlated with each other. by Benedict J. Alter (9745466)

“…No correlation exists between stimulus intensity (heat pain threshold (A or C) or T1 stimulus temperature used (B or D)) and pain intensity modulation during the t3 period by either preceding noxious temperature decreases (OS Min-T1) or increases (Inv Max-T2). Although an inverse correlation between onset hyperalgesia and offset analgesia does not achieve statistical significance when comparing local extrema (E), a significant inverse correlation is detected using within-stimulus change (F).…”

Summary of impacts on maternal child and health reported globally during the early COVID-19 pandemic and the experience at Kiwoko hospital. by Anna Hedstrom (11846840)

Subjects:

Regression analysis on longitudinal changes in depressive symptoms (<i>n</i> = 69). by Lisa Kertzscher (14053712)

Subjects:

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Diameter change (ΔD) in μm as function of diameter D for pig brain tissue. by R. C. M. Vulders (11846314)

Subjects:

Poisson regression analysis of negative changes in quality of life. by Le Dai Minh (14295271)

Subjects:

Patients’ histories are presented in decreasing length of observation and colour coded as red for the days of use or referred use and green for abstinence days. by Francesco Lolli (2530471)

Subjects:

Change in the number of Iba-1-positive cells in the dorsal root ganglia (DRG) of PSNL-exposed rats and the effect of treatment with MSCs. by Kanako Miyano (3805288)

Subjects:

Outline of study visits. by Jordan K. Abbott (8934239)

Subjects: